Phase 2 Study of SAR302503 in Patients With Myelofibrosis

Clinical trial NCT01420770 · COMPLETED

Trial details

NCT number: NCT01420770
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Neoplasm

Start date: 2011-08-01
Primary completion: 2014-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.